115 related articles for article (PubMed ID: 32357599)
21. Colorectal carcinoma and its precursors: role of argyrophilic nucleolar organizer regions (AgNORs).
Bufo P; Frassanito F; Maiorano E
Boll Soc Ital Biol Sper; 1992 Feb; 68(2):129-36. PubMed ID: 1324695
[TBL] [Abstract][Full Text] [Related]
22. Acinic cell carcinoma of salivary glands. Prognostic relevance of DNA flow cytometry and nucleolar organizer regions.
Timon CI; Dardick I; Panzarella T; Patterson B; Thomas MJ; Ellis GL; Gullane PJ
Arch Otolaryngol Head Neck Surg; 1994 Jul; 120(7):727-33. PubMed ID: 8018325
[TBL] [Abstract][Full Text] [Related]
23. Pituitary adenoma: a DNA flow cytometric study of 192 clinicopathologically characterized tumors.
Gaffey TA; Scheithauer BW; Leech RW; Blick K; Kovacs K; Horvath E; Weaver AL; Lloyd RV; Ebersold M; Laws ER; DeBault LE
Clin Neuropathol; 2005; 24(2):56-63. PubMed ID: 15803804
[TBL] [Abstract][Full Text] [Related]
24. The argyrophilic nucleolar organizer regions in ductal carcinoma in situ of the breast. The significance of ploidy and proliferative activity analysis using this silver staining technique.
Mourad WA; Setrakian S; Hales ML; Abdulla M; Trucco G
Cancer; 1994 Sep; 74(6):1739-45. PubMed ID: 8082076
[TBL] [Abstract][Full Text] [Related]
25. Proliferating cell nuclear antigen and nucleolar organizer regions in CNS tumors: correlation with histological type and tumor grade. A comparative study of 82 cases on paraffin sections.
Korkolopoulou P; Christodoulou P; Papanikolaou A; Thomas-Tsagli E
Am J Surg Pathol; 1993 Sep; 17(9):912-9. PubMed ID: 8102513
[TBL] [Abstract][Full Text] [Related]
26. Nucleolar organizer regions in hepatocellular carcinoma related to the cell cycle, cell proliferation and histologic grade.
Nagao T; Ishida Y; Yamazaki K; Kondo Y
Pathol Res Pract; 1995 Oct; 191(10):967-72. PubMed ID: 8838363
[TBL] [Abstract][Full Text] [Related]
27. Argyrophilic nuclear organizer regions in nasopharyngeal carcinoma and paraneoplastic epithelia.
Chen M; Lee JC; Lo S; Shen J
Head Neck; 2003 May; 25(5):395-9. PubMed ID: 12692877
[TBL] [Abstract][Full Text] [Related]
28. Pathobiology of pituitary adenomas and carcinomas.
Scheithauer BW; Gaffey TA; Lloyd RV; Sebo TJ; Kovacs KT; Horvath E; Yapicier O; Young WF; Meyer FB; Kuroki T; Riehle DL; Laws ER
Neurosurgery; 2006 Aug; 59(2):341-53; discussion 341-53. PubMed ID: 16883174
[TBL] [Abstract][Full Text] [Related]
29. Analysis of pituitary hormones and chromogranin A mRNAs in null cell adenomas, oncocytomas, and gonadotroph adenomas by in situ hybridization.
Lloyd RV; Jin L; Fields K; Chandler WF; Horvath E; Stefaneanu L; Kovacs K
Am J Pathol; 1991 Sep; 139(3):553-64. PubMed ID: 1653518
[TBL] [Abstract][Full Text] [Related]
30. Nucleolar organiser regions in pituitary adenomas.
McNicol AM; Colgan J; McMeekin W; Teasdale GM
Acta Neuropathol; 1989; 77(5):547-9. PubMed ID: 2470231
[TBL] [Abstract][Full Text] [Related]
31. Interphase nucleolar organizer regions in the evaluation of serosal cavity effusions.
Carrillo R; Sneige N; el-Naggar AK
Acta Cytol; 1994; 38(3):367-72. PubMed ID: 8191825
[TBL] [Abstract][Full Text] [Related]
32. Relationships among DNA Index, S-Phase, and invasive behavior in anterior pituitary adenomas. A cytometric study of 61 cases with Feulgen-positive DNA analysis.
Mastronardi L; Guiducci A; Buttaro FM; Cristallini EG; Puzzilli F; Maira G
Surg Neurol; 2001 Jul; 56(1):27-32. PubMed ID: 11546567
[TBL] [Abstract][Full Text] [Related]
33. Nucleolar organizer regions in glottic carcinomas: comparison of DNA cytofluorometry and clinicopathological analysis.
Yamamoto Y; Itoh T; Saka T; Sakakura A; Takahashi H
Eur Arch Otorhinolaryngol; 1995; 252(8):499-503. PubMed ID: 8719595
[TBL] [Abstract][Full Text] [Related]
34. Measurement of cellular proliferation in human prostate by AgNOR, PCNA, and SPF.
Sakr WA; Sarkar FH; Sreepathi P; Drozdowicz S; Crissman JD
Prostate; 1993; 22(2):147-54. PubMed ID: 7681206
[TBL] [Abstract][Full Text] [Related]
35. Expression of cell proliferation markers in pituitary adenomas--correlation and clinical relevance of MIB-1 and anti-topoisomerase-IIalpha.
Wolfsberger S; Wunderer J; Zachenhofer I; Czech T; Böcher-Schwarz HG; Hainfellner J; Knosp E
Acta Neurochir (Wien); 2004 Aug; 146(8):831-9. PubMed ID: 15254805
[TBL] [Abstract][Full Text] [Related]
36. [The proliferative potential of human pituitary macroadenomas on the basis of morphometric analysis of nucleolus organizer regions].
Szymaś J; Liebert W; Beil M
Neurol Neurochir Pol; 1999; 33(5):1089-97. PubMed ID: 10672560
[TBL] [Abstract][Full Text] [Related]
37. AgNORs in ductal breast cancer: correlation with ploidy and S-phase fraction by DNA flow cytometry.
Borgiani L; Cogorno P; Oliviero J; Toso F; Gambini G; Tunesi G; Canepa M
Eur J Histochem; 1994; 38(2):171-6. PubMed ID: 7524814
[TBL] [Abstract][Full Text] [Related]
38. Role of nucleolar organiser regions in differentiating malignant from benign tumours of the colon.
Yang P; Huang GS; Zhu XS
J Clin Pathol; 1990 Mar; 43(3):235-8. PubMed ID: 2332519
[TBL] [Abstract][Full Text] [Related]
39. Fine needle aspiration cytology combined with argyrophilic nucleolar organizer regions (AgNORs) in diagnosis of thyroid neoplasms.
Szot W; Szybiński Z; Zaczek M; Kedra D; Dabroś E; Piotrowska K; Chłap Z
Endokrynol Pol; 1993; 44(4):413-26. PubMed ID: 7519978
[TBL] [Abstract][Full Text] [Related]
40. Demonstration of silver-stained nucleolar organizer region associated proteins (AgNORs) after wet autoclave pretreatment in breast carcinoma: correlation to tumor stage and long-term survival.
Ofner D; Bier B; Heinrichs S; Berghorn M; Dünser M; Hagemann HA; Langer D; Böcker W; Schmid KW
Breast Cancer Res Treat; 1996; 39(2):165-76. PubMed ID: 8872325
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
